Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers

BACKGROUND: Current risk models for renal cell carcinoma (RCC) based on clinicopathological factors are sub-optimal in accurately identifying high-risk patients. Here, we perform a head-to-head comparison of previously published DNA methylation markers and propose a potential prognostic model for cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Joosten, S. C., Odeh, S. N. O., Koch, A., Buekers, N., Aarts, M. J. B., Baldewijns, M. M. L. L., Van Neste, L., van Kuijk, S., Schouten, L. J., van den Brandt, P. A., Tjan-Heijnen, V. C., van Engeland, M., Smits, K. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094610/
https://www.ncbi.nlm.nih.gov/pubmed/33947447
http://dx.doi.org/10.1186/s13148-021-01084-8

Ejemplares similares

Ejemplares similares